Autoimmune disorders reported following COVID-19 vaccination: A disproportionality analysis using the WHO database
ConclusionIn addressing the imperative to comprehend AEFI related to autoimmune disorders following COVID-19 vaccination, our study identified four potential safety signals. Thus, our research underscores the importance of proactive safety monitoring for the identification of the four AEFIs following COVID-19 vaccination, considering the associated advantages.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Ankylosing Spondylitis | Arthritis | Autoimmune Disease | Coronavirus | Covid Vaccine | COVID-19 | Databases & Libraries | Drugs & Pharmacology | Inflammatory Bowel Disease | International Medicine & Public Health | Polymyalgia Rheumatica | Psoriatic Arthritis | Rheumatology | Study | Thyroiditis | Vaccines | WHO